SCHEMBL650473

SCHEMBL650473

CCCCn1c(-c2ccccc2)nc(-c2ccccc2)c1CN(Cc1ccc(OC(F)F)cc1)Cc1ccc(F)c(Br)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.41
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TSHR P16473 2/20 0.33
HTT P42858 2/20 0.33
ALDH1A1 P00352 2/20 0.33
PPARG P37231 2/20 0.32
PPARA Q07869 2/20 0.32
LMNA P02545 1/20 0.31
BCHE P06276 1/20 0.31
DAGLA Q9Y4D2 1/20 0.31
ATP4A P20648 1/20 0.31
ATP4B P51164 1/20 0.31
BACE1 P56817 2/20 0.31
MMP13 P45452 1/20 0.31
KDM4E B2RXH2 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5136200 0.91 C5AR1 (0.43) C5AR1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL648089 0.91 C5AR1 (0.47) C5AR1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL651033 0.91 C5AR1 (0.44) C5AR1TSHRHTTALDH1A1LMNA
SCHEMBL649882 0.90 C5AR1 (0.41) C5AR1TSHRHTTALDH1A1LMNA
SCHEMBL651956 0.90 C5AR1 (0.43) C5AR1TSHRHTTALDH1A1LMNA
SCHEMBL1913005 0.89 C5AR1 (0.42) C5AR1NPSR1TSHRHTTALDH1A1
SCHEMBL647750 0.89 C5AR1 (0.39) C5AR1NPSR1TSHRHTTALDH1A1
SCHEMBL652220 0.89 C5AR1 (0.41) C5AR1NPSR1TSHRHTTALDH1A1
SCHEMBL648790 0.88 C5AR1 (0.43) C5AR1TSHRHTTALDH1A1PPARG
SCHEMBL649675 0.88 C5AR1 (0.42) C5AR1NPSR1TSHRHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
EP-1490044-A4 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORP (US) 2008-04-16 EP disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
EP-1490044-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2004-12-29 EP disclosed
WO-2003084524-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2003-10-16 WO disclosed